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Niemann–Pick disease (NPD) is a rare, inherited, autosomal recessive, lipid storage disease. The pathognomonic
intracellular accumulation of sphingomyelin results in the production and accumulation of ‘foam cells’. Interstitial
lung disease is a rare manifestation of NPD. We present the case of a 48-year-old white female with NPD involving
the lungs, liver and spleen. The chest radiograph showed bilateral, predominantly basal reticulonodular infiltrates
and serial pulmonary function tests over a period of years showed preserved expiratory airflow and a severely
decreased diffusion capacity for carbon monoxide (DLCO). In view of her visceral involvement, lack of
neurological symptoms and survival into adulthood, we believe our patient represents a case of type B NPD. In this
type of NPD, aside from prominent hepatosplenomegaly and sexual immaturity, significant pulmonary infiltration
with ‘Pick cells’ has been reported. To date, no therapeutic modality has been shown to alter the natural history of
this disease, which results in progressive debilitation and death. This case is unique in that it provides the longest
physiological follow-up in the literature, and provides data on the natural history of pulmonary involvement in
NPD.
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Niemann–Pick disease (NPD) is a rare syndrome char-
acterized by the intracellular deposition of sphingomyelin.
Presumed to be an infantile variant of Gaucher’s disease in
the initial report by Niemann (1), Pick later recognized it as
a distinct entity (2,3). Over the years, it has become
apparent that NPD is a clinically and biochemically
heterogeneous disorder, with six variants of NPD (types
A to F) currently described (4). The exact incidence of
pulmonary involvement with NPD is dicult to determine
since the literature mostly consists of isolated case reports.
The disease is characterized by the presence of groups of
lipid-laden (mainly spingomyelin and cholesterol) cells with
‘foamy’ cytoplasm, so-called ‘Pick’ cells, in various body
tissues. The disease may become manifest in infancy and
follow a rapid course of death by 3 years of age, or it may
follow a more protracted course (5 –7). The predilection forReceived 16 June 2000 and accepted in revised form 17 August
2000.
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0954-6111/00/121241+11 $35?00/0involvement of the reticuloendothelial system and, in some
cases, the nervous system, results in bone marrow involve-
ment, variable hepatosplenomegaly and, in some types,
neurological symptoms. Type B NPD develops as a result
of sphingomyelinase deficiency and is characterized by
prominent hepatosplenomegaly, absence of neurologic
involvement and a chronic, protracted course. Pulmonary
parenchymal involvement may be a feature of several types
of NPD, including type B.
The current report presents a patient with type B NPD
with pulmonary involvement and reviews the available
experience regarding pulmonary involvement with NPD.
Case report
The patient is a 48-year-old white female who was referred
to the Cleveland Clinic Foundation for an abnormal chest
radiograph. She had a history of Niemann–Pick disease for
which she underwent a splenectomy at 12 years of age
(which revealed replacement of splenic pulp by PAS-
positive large histiocytes and ‘foam’ cells) and an ortho-
topic liver transplant at 41 years of age. She was first noted
to have an abnormal chest radiograph, characterized by
bilateral predominantly basal reticulonodular infiltrates, at
41 years old. A flexible bronchoscopy with transbronchial# 2000 HARCOURT PUBLISHERS LTD
FIG. 1. (a) PA and (b) lateral views of the chest showing
diffuse interstitial markings bilaterally with an old
granuloma in the right upper lobe. No lymphadenopathy
or pleural effusions were noted.
1242 O. A. MINAI ET AL.biopsies was performed at an outside facility and was said
to be consistent with ‘fibrosis’ but the slides were not
available for review. At that time, she was able to function
normally and required oxygen with exertion only.
At the time of her evaluation in our institution at 48 years
of age, her pulmonary symptoms had been stable over the
last few years. She was able to walk approximately 1mile
on a treadmill with oxygen and she did not have a cough.
Apart from the NPD, her past medical history was
significant for aortic valve replacement 3 years earlier for
severe aortic stenosis, CMV pneumonia 6 years earlier and
hypertension. She was a former smoker of 10 –15 pack-
years, having quit 11 years earlier.
Her physical examination revealed a healthy female with
a few faint crackles at both lung bases and a 3/6 systolic
murmur at the base of the heart. No signs of cor pulmonale
were noted.
Her chest radiograph [Figs 1(a) and (b)] showed diffuse
interstitial markings bilaterally with an old granuloma in
the right upper lobe. No lymphadenopathy or pleural
effusion was noted. An echocardiogram showed a small left
ventricular cavity with normal systolic function. A CT scan
of the chest showed diffuse bilateral interstitial lung disease
with basal predominance (Fig. 2). A few small calcified gra-
nulomata were seen in the lung bases. Her oxygen satu-
ration was 94% at rest on room air. After walking 250 feet on
3 lmin71 oxygen via nasal cannula, her saturation was 91%.
Her pulmonary function tests (Fig. 3) showed preserved
flow rates and lung volumes with a severely decreased
diffusion capacity for carbon monoxide (DLCO),
5?58mlmin71mmHg71 (29% of predicted).
Discussion
Niemann–Pick disease is a rare, inherited, autosomal
recessive disease characterized by abnormal sphingomyelin
lipid storage. The pathognomonic intracellular accumula-
tion of sphingomyelin in NPD may result from a variety of
biochemical derangements, including lysosomal sphingo-
myelinase deficiency and altered intracellular cholesterol
processing (4), which are associated with the accumulation
of ‘foam cells’. This biochemical heterogeneity may help to
explain the significant variability noted in the clinical
presentation. Although the diagnosis is usually established
in childhood, the disease may rarely be first recognized in
adolescence or adulthood (6).
‘Sea-blue histiocytes’ have been described in patients with
NPD and are known as ‘Pick cells’ (7–11). However, the
relationship of NPD with the syndrome of ‘sea-blue
histiocytosis’ has been an area of some controversy. In
1947, Moeschlin (12) described splenic macrophages that
stained deep blue with May–Grunwald Giemsa stain. Since
then, ‘sea-blue histiocytes’ have been described in approxi-
mately 30 different diseases (7,13) as well as in isolation, i.e.
without a known primary disorder (14). Some (15) have
argued that ‘sea-blue histiocytes’ represent a normal
reticuloendothelial cell that contains partially digested cells.
To review all available reports, a Medline search of
English language reports using the words ‘Niemann–Pickdisease’ and ‘lipid storage disease’ was performed. Tables 1
and 2 present the clinical characteristics of patients with
NPD and pulmonary involvement in 31 previous reports.
The current patient extends this experience to 32 and is
unique in many respects. It provides the longest physiolo-
gical follow-up in the literature, provides data on the
natural history of pulmonary involvement in NPD, and
highlights the fact that lung volumes and flow rates may be
preserved even in advanced NPD with interstitial infiltrates
and severely decreased DLCO. Although it is tempting to
speculate that the aortic stenosis may have been due to an
infiltrative process such as NPD, the patients’ histopathol-
FIG. 2. A high resolution CT scan of the chest, at the level of the aortic arch, showing diffuse bilateral interstitial lung
disease.
FIG. 3. Graph showing results of serial pulmonary function testing in our patient (in % predicted). These showed preserved
spirometric flow rates and lung volumes over time, with severely decreased DLCO and DLVA.^: FVC;&: FEV1;~: TLC
(He); 6: DLCO; *: DLVA.
PULMONARY INVOLVEMENT IN NIEMANN–PiCK DISEASE 1243ogy was not available for review and our review of the
literature did not reveal any previous reports of valvular
involvement specifically with NPD.
RADIOGRAPHIC FEATURES
As presented in Table 2, radiographic features of NPD
include diffuse linear interstitial and nodular infiltrates withbasal predominance, and honeycombing (7,30,36,40). The
infiltrates may initially involve only the base and later
progress to involve the entire lung field (30). High
resolution computed tomography of the lung (Table 2)
may show ground-glass opacities in the upper lung zones,
possibly due to partial filling of the alveoli with ‘Pick cells’
and thickening of the interlobular septa in the lower lung
zones (6,36,37). Pleural disease and lymphadenopathy have
not been observed (6,36,37) and cavitary infiltrates are rare,
TABLE 1. Demographic features and presenting characteristics of reported patients with pulmonary involvement in Niemann–Pick disease*
Reference Age at
diagnosis,
gender
Age at report Type Presentation Physical examination Diagnostic test
Knox [16] NK HSM HSM, cherry spot
on fundus
Autopsy
Bloom [17] 16 months 16 months NK GR, DD, diarrhea LAN, rash, rales Autopsy
7 months 7 months NK Cough, fever, coma, seizures Comatose, HSM Autopsy
Abt [18] 14 months 14 months NK HSM, rhinopharyngitis HSM, fever Liver, splenic bx
Karelitz [19] NR NR NK HSM, listlessness, nystagmus HSM, rotatory nystagmus BM smear
Videbaek [20] 26 months 26 months NK DD, HSM, skin pigmentation
(26 months).
Epistaxis (4 years)
SM, LAD BM, liver, splenic bx
Terry [21] 53 years 53 years NK Easy fatigability, SOB, cough, hemoptysis Cyanosis, HSM Lung bx, autopsy
Crocker [6] 1 month — 6 years, M NR NK 18 patients With variable symptoms. Bouts
of bronchopneumonia
SM, Fe, LAN Bm bx, LN bx
Forsythe [22] 10 years 19 years NK DD SM Splenic bx
4 years 9 years
2 months
NK Abdominal distension SM BM bx
5 years 10 years NK SM SM BM bx
Fritts [23] 51 years 51 years NK Confusion, weakness,
SOB
Cyanosis Autopsy
Lynn [24] 19 years 19 years ?B Night sweats, mild SOB, fatiguability HSM, LAN BM bx, LN bx
Lowden [25] 18 months 3 years
10 months
B PMR, DD HSM, retinal ‘cherry
red’ spot
BM
Skikne [26] 12 years, M NR NK Abnormal CXR Unremarkable Lung bx
Kawai [27] 2 years, M 2 years B SOB, fever, stridor, vomiting HSM BM bx
Long [7] 3 years, F 33 years NK HSM, SS, DSM HSM, clubbing
(33 years)
BM bx, liver bx
15 years, F 15 years NK HSM, abnormal, CXR, easy bruising DSM, SN, ecchymosis liver bx
15 years, F 15 years NK Anorexia, recurrent epistaxis, GIB HSM, bruises BM bx
Fried [11] 17 months NR B HSM, anemia HSM BM bx
Dewhurst [9] 25 years 25 years B Malaise, abdominal distension HSM,CLD, DSM BM
Reich [28] 2 years, M 5 years B HSM HSM BM bx
Hammeren [29] 2 years
8 months
4 years B Bronchopneumonia, HSM HSM BM bx
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Lever [30] 7 years, F 26 years ?B HSM, GR, abn CXR HSM BM bx
Pavone [31] 2 years, F 17 years B Recurrent pulmonary infections, Abnormal
CXR
HSM, skin rash,
DSM, GR
BM bx, liver bx
Lipson [32] 14 months NR B HSM, episodes of pneumonia HSM BM, liver bx
Takada [33] 15 months, F 5?5 years ?B HSM HSM, macular
‘change’
BM bx
Zina [13] 38 years, M 38 years NK Skin involvement Skin rash and
exophytic
lesions{
BM bx, skin bx
Putterman [10] 12 years 36 years B DSM, CLD,HSM CLD,HSM BM
Viana [34] (on
four patients)
3?5–22 years, 2F/2M 3?5–22
years
B NR HSM, poor breast
development
BM bx, liver bx
Gogus [8] 8 years,F 8 years ?B Failure to thrive SM BM bx, lung bx
3 years, M 3 years ?B Abnormal CXR HSM BM bx
Niggemann [35] 2 years, F 13 years B Abnormal CXR SM BM bx
3.5 years, M 3.5 years B Excessive sweating,
abnormal CXR
HSM, PMR BM
Ferretti [36] 10 years,F 23 years ?B Tpenia, abnormal
CXR
SM lung bx
Kovesi [37] 18 months, M NR C Respiratory,
distress, dry cough,
jaundice, hypotonia, DD
HSM BM asp
Muntaner [38] 62 years, F 62 years B Epigustric pain, N/V HSM BM bx, liver bx
Schofer [39] 3 months 3 months C Severe interstitial
pneumonia
HSM OLBx, liver, BM, skin bx
Minai} 12 years, F B HSM HSM
*Case reports identiifed by Medline search with key words ‘Niemann–Pick disease’ and ‘lipid storage disease’.
{Single case reports unless otherwise indicated.
{Disfiguring exophytic lesions on face, hands and feet.
}Present report.
Abbreviations: BM: bone marrow; bx: biopsy; CLD: chronic liver disease; CXR: chest radiograph; DD: developmental delay; DSM: delayed sexual maturity; F: female;
GR: growth retardation; HM: hepatomegaly; HSM: hepatosplenomegaly; LAN: lymphadenopathy; LN: lymph node; M: male; N: nausea; NK: not known; NR: not
reported; PMR: psychomotor retardation; SM: splenomegaly; SN: spider nevi; SOB: shortness of breath; SS: short stature; Tpenia: thrombocytopenia; V: vomiting.
Types of NPD. A: acute neuronopathic; B: chronic non-neuropathic; C: chronic neuronopathic; D: Nova Scotia variant; E: adult non-neuronopathic; ?denotes type is
presumed.
P
U
L
M
O
N
A
R
Y
IN
V
O
L
V
E
M
E
N
T
IN
N
IE
M
A
N
N
–P
iC
K
D
IS
E
A
S
E
1245
TABLE 2. Characteristics of pulmonary involvement in patients with Neimann–Pick disease*
Age at
Pulmonary
diagnosis
Pulmonary
symptoms
Pulmonary
examination
findings
Chest
radiograph
CT scan PFT
NR NR NR ND ND
16 months Pneumonia Basal rales Marked diffuse mottling
bilaterally
ND ND
7 months Cough Coarse rales NR ND ND
14 months Rhinopharyngitis ‘Stertorous’
breathing
Accentuated bilateral
bronchial markings and
infiltration ‘along the
finer ramifications’
ND ND
NR None NR Diffuse nodular infiltration ND ND
26 months OM, cough,
bronchopneumonia
None Diffuse bilateral speckled,
lacy pattern
ND ND
53 years Cough, hemoptysis Cyanosis,
bilateral
inspiratory rales
Extensive symmetrical
reticulated pattern (EAB)
ND ND
6 months–
19 years
Cough None 11 of 18 patients with abnormal
CXR. Most commonly
‘miliary infiltration’ (N=6)
ND ND
10 years None NR ling Diffuse miliary mottling
(7 years), coarse mottling and
reticular (18 years)
ND ND
4 years None None Symmetrical soft mottling
bilaterally
ND ND
5 years None None Diffuse fine mottling bilaterally ND ND
51 years SOB Cyanosis Bilateral mottling, hilar shadows ND Mild restrictive
defect
19 years Mild DOE None Diffuse coarse retic pattern (EAB).
No LAN
ND ND
18 months URTI NR Bilateral diffuse perihilar infiltration
(18 months), fine retic network of
increased densities (3 years), heavy
diffuse infiltration (3 years 10 months)
ND ND
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12 years None None Diffuse mottling ND ND
2 years Dyspnea, stridor None NR ND ND
3 years DOE (age
33 years)
Clubbing Diffuse mottling, widespread internal
shadows
ND Normal lung
volumes flow
rates, decreased
DLCO (TF)
15 years None None Widespread interstitial shadows,
septal lines at bases (age 15 years)
Reportedly abnormal at age 5 years.
ND HI, decreased
DLCO (550%
predicted)
15 years Recurrent
epistaxis
None Diffuse fine reticular (EAB) ND ND
17 months None None Fine symmetrical reticular
densities bilaterally thick ILF
ND ND
25 years None None Generalized infiltration (25 years).
First noted at age 7 years
ND Mild restrictive
defect
NK None None Bilateral interstitial infiltration
(2 years). Increased at 4 years
ND ND
2 years 8 months Pneumonia Pneumonia Bilateral diffuse RN infiltration
(first noted at 11 months). Stable
over time
ND ND
7 years Dyspnea Cor pulmonale Coarse reticular shadows
bilaterally (EAB).
Worsening infiltration
at 18 years
ND Restrictive defect
(see text)
2 years Recurrent
pulmonary
infections
None Coarse, bilaterally RN
infiltration
ND ND
3?5 years Pneumonia Pneumonia Bilateral diffuse interstitial
infiltration (stable over time)
ND Normal
15 months None None Diffuse, bilateral, RN infiltration ND ND
38 years None None Diffuse nodular
infiltration þ cavitation ND ND
34 years None NR Markedly increased
interstitial markings (EAB)
ND Severe restrictive
lung disease
3?5–22 years
(four patients)
NR None Diffuse interstitial infiltration ND ND
8 years None None Bilateral diffuse RN infiltration ND ND
3 years None None Bilateral fine reticular infiltration ND ND
13 years None None Bilateral symmetrical RN infiltration ND Normal (see text)
3?5 years None None Bilateral fine reticular infiltration
Unchanged 6 months later
ND ND
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TABLE 2. (continued)
Age at
Pulmonary
diagnosis
Pulmonary
symptoms
Pulmonary
examination
findings
Chest
radiograph
CT scan PFT
23 years None None Fine reticular basal infiltration ULþML:
nodular,
CL GGO,
thick ILS
LL: Thick
ILS, less
GGO, no
nodules.
No LAN,
normal BVB
Normal
spirometryþ
volumes.
Moderately
decreased DLCO
(56%)
Normal ABG
3 years Dyspnea,
dry cough
Adventitial
sounds
Diffuse reticular pattern, increased
density R lung þ L perihilar
(36 months)
Diffuse
interstitial þ
AS involvement
(42 months)
ND
62 years None None NR Mild interstital
pattern
ND
3 months Severe interstitial
pneumonia
Pulmonary
insuciency
Diffuse RN infiltration (3 months)
increased lung density (4 months)
ND ND
41 years None None Bilateral basal RN infiltration Diffuse
bilateral
Basal
RN infiltration
See Fig. 1
*Case reports identified by Medline Search with key words ‘Niemann–Pick disease’ and ‘Lipid storage disease’.
Abbreviations: AS: airspace; BVB: bronchovascular bundles; CL: centrilobular; CT: computerized tomographic scan; CXR: chest radiograph; EAB: especially at the bases;
GGO: ground glass opacity; HI: hyperinflation; ILF: interlobar fissures; ILS: interlobular septa; LAN: lymphadenopathy; LL: lower lobe; ML: middle lobe; ND: not done;
NK: not known; NR: not reported; OM: otitis media; PFT: pulmonary function tests; RN: reticulonodular; TF: transfer factor; thick: thickened; UL: upper lobe; URTI:
upper respiratory tract infection.
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TABLE 3. Pulmonary histopathological findings reported in 16 patients described with Niemann–Pick disease
Reference Type of biopsy Pathology
16 Autopsy LM: Thickened interstitium with infiltration by ‘vacuolated’ cells. Large pale cells
in the walls of pulmonary arteries and veins with patchy luminal obliteration.
17 Autopsy Gross: Large, dark red, congested, edematous. No induration. No LAN.
LM: Large, multi-nucleate, foam cells filling alveolar spaces, peribronchial
connective tissue, alveolar capillaries and pulmonary artery branches, PMN alveolar
infiltrate. An area of ‘lymphoid’ cells.
17 Autopsy Gross: Reddish. No masses. Mottled, gray, pink on section.
LM: Alveoli completely filled with large, spheroidal or polygonal foam cells (especially
in subpleural and paraseptal alveoli). Foam cells also seen in bronchi and pulmonary
artery branches. The cells stained intensely black with Weigert’s iron hematoxylin stain.
19 Autopsy Widespread involvement of the lungs with Niemann–Pick foam cells.
21 Lung bx,
autopsy
Lung bx: Collections of intra-alveolar foam cells.
Autopsy: Gross: gray-green pleural surface with minute, yellow points. A frothy,
greasy material which did not float on water was expressible from the cut surface.
Normal tracheobronchial tree. Hilar lymph nodes moderately enlarged. LM: Lipid
Laden histiocytes (30–60 m, cytoplasm filled with acidophilic foam, large nuclei
2–3 cells) filling alveoli and to a lesser extent alveolar septa which were ‘sclerotic’.
Slight hyperplasia of the subintimal layer of the small pulmonary arteries and arterioles.
6 Autopsy (11
of 18 had
lungs examined)
8 to 11 patients had Niemann–Pick cells (foamy cells) in alveoli, alveolar septae,
tracheal and bronchial walls and pleura. Variable severity. Bronchopneumonia in
all autopsy specimens.
23 Autopsy Fat-laden cells with a high phospholipid content almost completely replacing the
alveoli.
25 Autopsy Gross: ‘Yellowish infiltration’ and marked increase in weight.
LM: Foam cells.
26 Not known EM: Alveoli filled with ‘foamy’ cells containing membranous cytoplasmic bodies
made up of stacks of lamellae, alternately osmiophilic and osmiophobic, giving a
vacuolated appearance. Alveolar epithelial cells containing ‘myelin bodies’. Edema
of the basement membrane.
27 Autopsy Foamy cells in intra-alveolar spaces.
5 Autopsy Foamy cells present in alveoli.
35 Not known Foamy cells in alveolar spaces and interstitium.
8 OLBx LM: Nodular clusters of Oil Red O and Sudan Black B positive foamy histiocytes in
alveoli especially in perivascular, peribronchial and subpleural areas. ‘Sea-blue’
histiocytes appearance in some cells.
EM: Intracytoplasmic lamellated membranous bodies or fine granular material
36 OLBx Foamy macrophages (20–90 mm diameter, vacuolated cytoplasm) in alveoli+
thickened alveolar walls, filling lymphatic spaces around peripheral bronchi and peripheral.
PA branches and subpleural and interlobular connective tissue. Rare giant
cell forms. No granulomas, no fibrosis.
37 OLBx LM: Large foamy macrophages in alveolar spaces and in thickened alveolar walls.
Alveoli showed changes ‘typical of alveolar proteinosis’.
EM: Intra-alveolar macrophages containing membrane bound cytoplasmic vacuoles
with concentric lamellated bodies ‘typical of storage cells seen in NPD’.
39 OLBx Massive alveolar and partly interstitial infiltration of macrophages loaded with
foamy storage material.
Abbreviations: EM: electron microscopy; LAN: lymphadenopathy; LM: light microscopy; OLBx: open lung biopsy; PA:
pulmonary artery; PMN: polymorphonuclear; TBBx: transbronchial biopsy.
PULMONARY INVOLVEMENT IN NIEMANN–PiCK DISEASE 1249with only a single instance reported (37). The radio-
graphical differential diagnosis may include diseases invol-
ving the lung bases predominantly, with an interstitial
pattern such as idiopathic pulmonary fibrosis and asbes-tosis. Other (non-pulmonary) radiographic features of
NPD may include hepatosplenomegaly, metacarpal widen-
ing, osteoporosis and expansion of the marrow cavity of
long bones (40).
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As in the present case, pulmonary function tests (Table 2)
usually reveal normal lung volumes with a decreased
diffusion capacity for carbon monoxide (DLCO) (7).
Niggeman et al. (35) reported normal body plethysmo-
graphic lung volumes and exercise test results in one 13-
year-old patient. Ferretti et al. (36) reported normal lung
volumes and flows [FVC 3?72 (95% predicted), FEV1 3?4
(95% predicted)] and a decreased DLCO (56% predicted)
with normal arterial blood gases. Long et al. (7) reported
pulmonary function tests in two patients. One patient had
normal lung volumes and flow rates with a transfer factor
below predicted (11?0ml COmin71mmHg71; predicted
20?1) while the other patient demonstrated hyperinflation
with a transfer factor less than half the predicted value
(11?8ml COmin71mmHg71; predicted 24?0). As sug-
gested by decreased values of FVC in several patients
[Table 2 (9,10,30,41)], restrictive changes can occur. Other
physiological features can include decreased maximal
breathing capacity (24) and exercise desaturation (24).
HISTOPATHOLOGY OF PULMONARY
INVOLVEMENT
As reported in one patient by Niggeman et al. (35),
bronchoscopic findings included ‘remarkably rugged ap-
pearing mucosa’ which can bleed easily. In available
reports, cultures of aspirated secretions were negative and
BAL fluid showed ‘foam cells’ of PAS and Sudan black B
staining (35,41).
Histopathological features (Table 3) include diffuse
infiltration of the lymphatics, subpleural spaces, alveolar
walls and alveoli with ‘foamy histiocytes’. In a post-mortem
series of 11 patients, Crocker and Farber (6) found
Niemann–Pick cells in alveolar septa; tracheal and bronch-
iolar walls and pleura in 58% of patients. The underlying
pulmonary architecture is usually preserved (26). Inflam-
mation and fibrosis are generally not features of this disease
(36), although a few authors have described ‘sclerotic’
alveolar septae (21) and increased connective tissue around
the bronchi and vessels (16).
NATURAL HISTORY
The natural history of NPD varies among the six described
variants (A–F) (4,35). As a general rule, pulmonary
involvement is rare in the adult variants of NPD but is
more common in the infantile forms. Specifically, the
clinical course of type A NPD is dominated by storage
retinopathy, visceromegaly and neuronal involvement
presenting in early infancy and causing rapid deterioration
and a poor outcome. In contrast, the course of type B NPD,
or the chronic visceral form, is more slowly progressive and
does not involve the central nervous system. The diagnosis
of type B NPD may be made at the time of traumatic
rupture of an enlarged spleen or, infrequently, at post-
mortem examination. Lung involvement may be noted
incidentally on chest radiography, or during evaluation ofcough, dyspnea, or recurrent pulmonary infections. The
prognosis of type B NPD is more favorable than for type A
disease, with most patients surviving into adulthood. Type
C NPD is characterized by progressive visceral and
neurological involvement with a subacute disease course
and variable age at onset. Type D NPD (Nova Scotian)
represents a juvenile form of the disease with normal early
development. Neurological deterioration occurs in child-
hood and most patients die by 20 years of age. Patients with
adult type E NPD develop generalized organ involvement
(including lungs, liver, spleen and the central nervous
system), but too few cases have been reported to allow a
systematic description.
Definitive diagnosis and distinction from other inter-
stitial diseases may require a biopsy showing characteristic
Pick cell organ infiltration. The current case extends the
available experience by presenting the 32nd reported
patient with type B disease and pulmonary involvement.
Like others, our patient demonstrated basilar interstitial
infiltrates with a decreased diffusing capacity, exercise
desaturation, but preserved spirometric flow rates and
normal lung volumes.
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